In this 124th episode of Sober Head Podcast, Dr. Esra Çavuşoğlu, PhD welcomes Dr. David Perlmutter, MD. Dr. David Perlmutter, MD is a board-certified neurologist known for his work in preventive neurology and a six-time “New York Time”s bestselling author. His work focuses on the links between brain health, nutrition, metabolism, and neurodegenerative disease, and he is perhaps best known for his internationally acclaimed book “Grain Brain.” He serves on the editorial board of the “Journal of Alzheimer’s Disease” and is also a faculty member at the University of Miami Miller School of Medicine and Director of Neuroscience Research at Bryan Therapeutics.

In this episode, Dr. David Perlmutter explores the emerging science behind Alzheimer’s disease, cognitive decline, brain aging, and long-term brain health. We discuss how microglia, the brain’s immune cells, are influenced by insulin resistance, elevated blood sugar, ultra-processed foods, the gut-brain connection, and mitochondrial health. Dr. Perlmutter explains why Alzheimer’s risk may begin developing 10, 20, or even 30 years before noticeable symptoms appear, making prevention and metabolic health increasingly important earlier in life. We also explore p-tau217 testing, uric acid, GLP-1 drugs, gene therapies, and emerging approaches such as 40 Hz gamma light stimulation.

The central message is simple: when it comes to protecting the brain and supporting healthy aging, exercise, nutrition, quality sleep, and metabolic health remain some of the most powerful tools we have.

#EsraÇavuşoğlu #AyıkKafa #ElevatingLifeEvolvingHealth #Longevilab #DavidPerlmutter Dr. David Perlmutter, MD
Website: https://drperlmutter.com/about/
Instagram: https://www.instagram.com/davidperlmutter/

Special thanks to T.C. Istanbul Gedik University https://www.gedik.edu.tr/en/

00:00-06:18 Introduction to Dr. David Perlmutter.
06:18-11:47 Do Ultra-Processed Foods Increase Alzheimer’s Risk?
11:47-15:36 Microglia & Immunometabolism: The Brain’s Immune System
15:36-20:16 Alzheimer’s and the Beta-Amyloid Debate
20:16-23:39 Can Microglia Become Brain-Protective Again?
23:39-29:16 When Should Alzheimer’s Prevention Begin?
29:16-34:35 Why Do Alzheimer’s, Parkinson’s and MS Develop Differently?
34:35-36:59 Mitochondria, Metabolism and Brain Health
36:59-42:41 Uric Acid, Sugar and Alzheimer’s Risk
42:41-47:36 Which Tests Matter for Brain Health?
47:36-53:18 The Most Powerful Longevity Tools: Exercise, Sleep & Nutrition
53:18-55:33 GLP-1 Drugs and Parkinson’s Research
55:33-57:39 Gene Therapy and the Future of Brain Health
57:39-59:00 40 Hz Gamma Light and Alzheimer’s Research
59:00-1:00:09 Wrap up.

*About Ayık Kafa* Dr. Esra Çavuşoğlu, PhD, took her studies, starting from her personal treatment experiences and continuing with her clinical psychology education, to the next level by completing her PhD focused on Addiction. Dr. Esra in Ayık Kafa podcast discusses the world’s latest technologies, protocols, products and research in the fields of Biohacking and Longevity, while sharing first-hand information and experiences about the Disease of Addiction, as well as her latest academic studies.

*About Dr. Esra Çavuşoğlu, PhD* Longevilab’s founder, Dr. Esra, is a United States and internationally trained clinical psychologist and a certified addiction therapist in New York. She served as International Development Advisor on the Yale University Faculty of Medicine Clinical Advisory Board. She is the founder and supervisor of Gaziantep Oya Bahadır Yüksel Rehabilitation Center, Dr. Esra is the designer and implementer of the Turkey Rehabilitation Model. Dr. Esra founded the Contemporary Addiction Studies Association (ÇABAÇAD) in order to combat Turkey’s growing addiction problem.

Disclaimer The information and statements on our YouTube Channel Sober-Head are not intended to guide individuals towards medical diagnosis and treatment. Please consult with your doctor for medical diagnostic and treatment procedures. The content is shared for informational purposes only, derived from scientific studies prepared by EMC Medya Yayıncılık Ticaret Ltd. Şti.’s researchers, consultants, and authors/scientists, as well as compilations from publicly available public